These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 17621556)
1. Potentiation of Toll-like receptor-induced cytokine production by (1-->3)-beta-D-glucans: implications for the monocyte activation test. Kikkert R; Bulder I; de Groot ER; Aarden LA; Finkelman MA J Endotoxin Res; 2007; 13(3):140-9. PubMed ID: 17621556 [TBL] [Abstract][Full Text] [Related]
2. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Kobayashi M; Yoshiki R; Sakabe J; Kabashima K; Nakamura M; Tokura Y Br J Dermatol; 2009 Feb; 160(2):297-304. PubMed ID: 19016710 [TBL] [Abstract][Full Text] [Related]
3. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591 [TBL] [Abstract][Full Text] [Related]
4. Insoluble beta-glucan from the cell wall of Candida albicans induces immune responses of human THP-1 monocytes through Dectin-1. Li M; Liu ZH; Chen Q; Zhou WQ; Yu MW; Lü GX; Lü XL; Shen YN; Liu WD; Wu SX Chin Med J (Engl); 2009 Mar; 122(5):496-501. PubMed ID: 19323897 [TBL] [Abstract][Full Text] [Related]
5. Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants. Kikkert R; de Groot ER; Aarden LA J Immunol Methods; 2008 Jul; 336(1):45-55. PubMed ID: 18456276 [TBL] [Abstract][Full Text] [Related]
6. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622 [TBL] [Abstract][Full Text] [Related]
7. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2, 3, 4, 5 ligands and interleukin-4 synergistically induce TARC production in nasal polyp fibroblasts. Nonaka M; Ogihara N; Fukumoto A; Sakanushi A; Pawankar R; Yagi T Auris Nasus Larynx; 2008 Dec; 35(4):515-20. PubMed ID: 18375080 [TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of beta-glucans on porcine alveolar macrophages and bone marrow haematopoietic cell-derived dendritic cells. Chaung HC; Huang TC; Yu JH; Wu ML; Chung WB Vet Immunol Immunopathol; 2009 Oct; 131(3-4):147-57. PubMed ID: 19410299 [TBL] [Abstract][Full Text] [Related]
10. The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Bonnet MP; Beloeil H; Benhamou D; Mazoit JX; Asehnoune K Anesth Analg; 2008 Apr; 106(4):1142-9, table of contents. PubMed ID: 18349186 [TBL] [Abstract][Full Text] [Related]
11. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. Mrabet-Dahbi S; Dalpke AH; Niebuhr M; Frey M; Draing C; Brand S; Heeg K; Werfel T; Renz H J Allergy Clin Immunol; 2008 Apr; 121(4):1013-9. PubMed ID: 18234309 [TBL] [Abstract][Full Text] [Related]
12. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. Hasannejad H; Takahashi R; Kimishima M; Hayakawa K; Shiohara T J Allergy Clin Immunol; 2007 Jul; 120(1):69-75. PubMed ID: 17531301 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system. Lendemans S; Kreuzfelder E; Rani M; Bayeeh E; Schade FU; Flohé SB; Waydhas C; Flohé S J Trauma; 2007 Oct; 63(4):740-6. PubMed ID: 18089999 [TBL] [Abstract][Full Text] [Related]
14. Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2. Erridge C; Spickett CM; Webb DJ Cardiovasc Res; 2007 Jan; 73(1):181-9. PubMed ID: 17156768 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211 [TBL] [Abstract][Full Text] [Related]
17. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128 [TBL] [Abstract][Full Text] [Related]
18. Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. van der Kleij D; van den Biggelaar AH; Kruize YC; Retra K; Fillie Y; Schmitz M; Kremsner PG; Tielens AG; Yazdanbakhsh M J Infect Dis; 2004 Mar; 189(6):1044-51. PubMed ID: 14999608 [TBL] [Abstract][Full Text] [Related]
19. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Kopp A; Buechler C; Neumeier M; Weigert J; Aslanidis C; Schölmerich J; Schäffler A Obesity (Silver Spring); 2009 Apr; 17(4):648-56. PubMed ID: 19148127 [TBL] [Abstract][Full Text] [Related]
20. Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching. Adams EL; Rice PJ; Graves B; Ensley HE; Yu H; Brown GD; Gordon S; Monteiro MA; Papp-Szabo E; Lowman DW; Power TD; Wempe MF; Williams DL J Pharmacol Exp Ther; 2008 Apr; 325(1):115-23. PubMed ID: 18171906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]